🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
100 Servings
Single Vitamin and Mineral Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

12 mcg (60% DV)
✅ Within RDA (0.8× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.012mg UL 0.1mg
Calcium
260 mg (20% DV)

Other Ingredients

Vegetable Stearic Acid Vegetable Magnesium Silicate Vegetable Cellulose Silica

Label Claims — Verification

Nutrient
All Other
Approved Health
Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (71% of products) Approved Health (13% of products)

Target Groups

Adult (18 - 50 Years) Seniors/Mature (>50 Years) Menopause Gluten Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 1 to 2 tablets two - three times daily. Four tablets provide: 1040 mg calcium, 80% of the daily value.

⚠️ Warnings & Precautions

Tamper evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Caution: If you are pregnant or nursing, consult your physician before taking this product.

🧪 Formulation Notes

Regular exercise and a healthy diet with enough calcium helps all women approximately 11 to 35 years of age maintain good bone health and may reduce their high risk of osteoporosis later in life. For persons with a family history of osteoporosis, menopausal women, or elderly men and women, adequate calcium intake is linked to reduced risk of osteoporosis through the mechanism of slowing the rate of bone loss. Adequate calcium intake is important but daily intakes above 2000 mg are not likely to provide any additional benefits.

Formula 950 is a dietary supplement that meets USP standards for purity, potency, disintegration and dissolution.

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)

Now with vitamin D-3

"Calcium builds strong bones"

Gluten free

Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.

Made in USA

Additional Information

Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).

Formula 950

Compare to Citracal

Product Details

DSLD Entry Date 2021-11-19
Product Type Single Vitamin and Mineral
Form Tablet or Pill
DSLD ID 260437
Data Updated 2026-04-11

Research Evidence

511 Research Sources
57 Avg Quality Score
266 Meta Analysis
95 Systematic Review
76 Rct
49 Clinical Trial
12 Guideline
4 Regulatory Source
2 Cochrane Review
2 Other
2 Narrative Review
1 Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Calcium →

Compare Similar Products

View all Calcium products →